《全日总结》恒指升40点 港铁重返45元 阿里续扬近3%
市场观望中美贸易谈判进展，港股窄幅靠稳。恒指今早高开29点，早段曾倒跌47点见26,866点全日低位，其後曾倒升60点，但在27,000点遇阻，最终升40点或0.1%，收26,954点；国指升2点或不足0.1%，收10,620点。大市全日成交金额757.19亿元。沪、深港通南下交易录得净流入金额分别为10.08亿及7.98亿元人民币。
阿里巴巴(09988.HK)升3%报193.2元，成交103.54亿元。腾讯(00700.HK)跌0.2%报335元。美团点评(03690.HK)破顶升3.4%报104.2元，盘中高见105.5元。小米(01810.HK)升1.3%报8.73元。其他新经济股个别发展，IGG(00799.HK)及易鑫(02858.HK)各跌2.6%及4.1%，平安好医生(01833.HK)及众安在线(06060.HK)各升1.8%及1.3%。美图(01357.HK)跌4.5%报1.5元，盘中见1.49元上市新低。
主要传统股份方面，汇控(00005.HK)升0.3%报58.95元，友邦(01299.HK)升0.6%报79.8元，港交所(00388.HK)跌0.2%报248.2元。中资电讯股偏软，中移动(00941.HK)及中电信(00728.HK)各跌0.4%及0.7%，联通(00762.HK)跌1.1%。中国铁塔(00788.HK)跌1.2%。内银股建行(00939.HK)、工行(01398.HK)及中行(03988.HK)各升0.2%至0.3%。
地产股方面，希慎(00014.HK)升3%，领展(00823.HK)升1.8%，新世界(00017.HK)及长实集团(01113.HK)各升1.2%及1.1%，信置(00083.HK)跌1.8%。另外，港铁(00066.HK)获高盛唱好，股价升3.8%收45元，为升幅最大蓝筹。医药股中生制药(01177.HK)公布季绩後获多间大行唱好，但股价跌4.6%，为跌幅最大蓝筹。出口股创科(00669.HK)升2.6%。
晶片股造好，中芯国际(00981.HK)及华虹半导体(01347.HK)各升1.6%及3.8%，鸿腾(06088.HK)及信利(00732.HK)各跌6.9%及2.8%。
内需股方面，安踏(02020.HK)升1.6%报76.05元。李宁(02331.HK)升2.1%。万洲(00288.HK)及维他奶(00345.HK)各升2.5%及3.2%，百威亚太(01876.HK)及滔博(06110.HK)各跌1.7%及3.1%，汽车股吉利(00175.HK)亦跌1.3%。燃气股中国燃气(00384.HK)及建材股海螺水泥(00914.HK)各跌1.4%。
首控集团(01269.HK)停牌，停牌前下泻75.3%报0.45元，成交近3亿元，成实外教育(01565.HK)股东首控集团拟遭平仓而大量出售持股，成实外教育股价急跌32.7%报1.44元，成交15.34亿元。新东方在线(01797.HK)跌7.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
